ID: ALA2409821

Max Phase: Preclinical

Molecular Formula: C17H17ClFN3O3

Molecular Weight: 329.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc2ncnc(Nc3cccc(F)c3)c2c(OC)c1OC.Cl

Standard InChI:  InChI=1S/C17H16FN3O3.ClH/c1-22-13-8-12-14(16(24-3)15(13)23-2)17(20-9-19-12)21-11-6-4-5-10(18)7-11;/h4-9H,1-3H3,(H,19,20,21);1H

Standard InChI Key:  TXQJRSXMNVBCOQ-UHFFFAOYSA-N

Associated Targets(Human)

Mitogen-activated protein kinase; ERK1/ERK2 651 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BGC-823 3035 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-3 62116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bcap37 715 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 329.33Molecular Weight (Monoisotopic): 329.1176AlogP: 3.54#Rotatable Bonds: 5
Polar Surface Area: 65.50Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.39CX LogP: 3.13CX LogD: 3.13
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.77Np Likeness Score: -0.90

References

1. Zhang Y, Jin L, Xiang H, Wu J, Wang P, Hu D, Xue W, Yang S..  (2013)  Synthesis and anticancer activities of 5,6,7-trimethoxy-N-phenyl(ethyl)-4-aminoquinazoline derivatives.,  66  [PMID:23811258] [10.1016/j.ejmech.2013.05.043]

Source